Getinge shares dive as Q2 profit disappoints
This article was originally published in Clinica
Executive Summary
Getinge’s second-quarter sales came in ahead of analyst expectations, but profits fell short, noted Morgan Stanley’s Michael Jungling. The Swedish firm’s share price on the Stockholm exchange was down 4% at SEK167.30 ($24.58) as Clinica went to press on 15 July.